Suppr超能文献

基于队列研究荟萃分析方程计算的 10 年心血管风险与非酒精性脂肪性肝病严重程度的关系。

The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Endocrinol Metab (Seoul). 2016 Mar;31(1):86-92. doi: 10.3803/EnM.2016.31.1.86.

Abstract

BACKGROUND

We investigated the association between the severity of non-alcoholic fatty liver disease (NAFLD) and the estimated 10-year risk of cardiovascular disease (CVD) calculated by Pooled Cohort Equation (PCE) and Framingham risk score (FRS).

METHODS

A total of 15,913 participants (mean age, 46.3 years) in a health screening program were selected for analysis. The presence and severity of fatty liver was assessed by abdominal ultrasonogram. Subjects who drank alcohol more than three times a week were excluded from the study.

RESULTS

Among the participants, 57.6% had no NAFLD, 35.4% had grade I, 6.5% had grade II, and 0.5% had grade III NAFLD. Mean estimated 10-year CVD risk was 2.59%, 3.93%, 4.68%, and 5.23% calculated using the PCE (P for trend <0.01) and 4.55%, 6.39%, 7.33%, and 7.13% calculated using FRS, according to NAFLD severity from none to severe (P for trend <0.01). The odds ratio for ≥7.5% estimated CVD risk calculated using the PCE showed a higher correlation with increasing severity of NAFLD even after adjustment for conventional CVD risk factors (1.52, 2.56, 3.35 vs. the no NAFLD group as a reference, P<0.01) compared with calculated risk using FRS (1.65, 1.62, 1.72 vs. no NAFLD group as a reference, P<0.01).

CONCLUSION

In our study of apparently healthy Korean adults, increasing severity of NAFLD showed a higher correlation with estimated 10-year CVD risk when calculated using the PCE than when calculated using FRS.

摘要

背景

我们研究了非酒精性脂肪性肝病(NAFLD)严重程度与通过汇总队列方程(PCE)和弗雷明汉风险评分(FRS)计算的心血管疾病(CVD)10 年预计风险之间的关系。

方法

我们从健康筛查计划中选择了 15913 名参与者(平均年龄为 46.3 岁)进行分析。通过腹部超声评估肝脏脂肪的存在和严重程度。每周饮酒超过三次的受试者被排除在研究之外。

结果

在参与者中,57.6%无 NAFLD,35.4%为 I 级,6.5%为 II 级,0.5%为 III 级。使用 PCE 计算的 10 年 CVD 风险的平均值分别为 2.59%、3.93%、4.68%和 5.23%(趋势 P<0.01),使用 FRS 计算的分别为 4.55%、6.39%、7.33%和 7.13%,根据 NAFLD 从无到严重的严重程度(趋势 P<0.01)。使用 PCE 计算的≥7.5%估计 CVD 风险的比值比与 NAFLD 严重程度呈正相关,即使在调整了传统 CVD 危险因素后也是如此(1.52、2.56、3.35 与无 NAFLD 组作为参考,P<0.01),与使用 FRS 计算的风险比(1.65、1.62、1.72 与无 NAFLD 组作为参考,P<0.01)。

结论

在我们对韩国健康成年人的研究中,与使用 FRS 相比,使用 PCE 计算的 NAFLD 严重程度与估计的 10 年 CVD 风险呈更高的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfce/4803567/a0c9ae14a586/enm-31-86-g001.jpg

相似文献

4
Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems.
Healthcare (Basel). 2021 Jul 15;9(7):899. doi: 10.3390/healthcare9070899.
5
Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):298-304. doi: 10.1097/MEG.0000000000000286.
7
The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Atherosclerosis. 2009 Apr;203(2):581-6. doi: 10.1016/j.atherosclerosis.2008.07.024. Epub 2008 Jul 31.
9
Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.

引用本文的文献

1
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.
Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2.
2
Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases.
Crohns Colitis 360. 2023 Feb 2;5(1):otad004. doi: 10.1093/crocol/otad004. eCollection 2023 Jan.
3
Risk factors for cardiovascular disease among individuals with hepatic steatosis.
Hepatol Commun. 2022 Dec;6(12):3406-3420. doi: 10.1002/hep4.2090. Epub 2022 Oct 25.
5
Fatty Liver Disease: Diagnosis and Stratification.
Annu Rev Med. 2022 Jan 27;73:529-544. doi: 10.1146/annurev-med-042220-020407. Epub 2021 Nov 22.
7
Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.
Curr Hepatol Rep. 2020 Sep;19(3):315-326. doi: 10.1007/s11901-020-00530-0. Epub 2020 Jun 29.
8
Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver.
Diagnostics (Basel). 2020 Feb 26;10(3):129. doi: 10.3390/diagnostics10030129.
9
Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease.
Hepatol Commun. 2019 Jun 6;3(8):1050-1060. doi: 10.1002/hep4.1387. eCollection 2019 Aug.

本文引用的文献

1
Standards of medical care in diabetes--2015: summary of revisions.
Diabetes Care. 2015 Jan;38 Suppl:S4. doi: 10.2337/dc15-S003.
2
Imaging of non alcoholic fatty liver disease: A road less travelled.
Indian J Endocrinol Metab. 2013 Nov;17(6):990-5. doi: 10.4103/2230-8210.122606.
4
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39. Epub 2012 Jan 17.
5
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
7
Screening for cardiovascular risk in asymptomatic patients.
J Am Coll Cardiol. 2010 Mar 23;55(12):1169-1177. doi: 10.1016/j.jacc.2009.09.066.
9
The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.
Am J Gastroenterol. 2009 Aug;104(8):1953-60. doi: 10.1038/ajg.2009.238. Epub 2009 Jun 2.
10
The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Atherosclerosis. 2009 Apr;203(2):581-6. doi: 10.1016/j.atherosclerosis.2008.07.024. Epub 2008 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验